VerityRank
Back to Rankings
Koninklijke Philips N.V.
Brand VerifiedNetherlands

Koninklijke Philips N.V.

Philips

Philips Healthcare is the Dutch health technology conglomerate, founded in 1891 in Eindhoven, Netherlands. With Personal Health segment revenue of €3.7 billion and Connected Care revenue of €5.1 billion, the company employs over 77,000 people across 30+ facilities worldwide. Philips has transformed from a consumer electronics giant into a pure-play health technology leader.Strengths: Massive globa

NetherlandsEst. 189177000+€37 Billion (Personal Health)30+ factories in 15+ countriesNYSE: PHGScore 90

Business Nature

Philips operates a global distributed manufacturing network with 30+ facilities across 15+ countries. The company has transformed from electronics manufacturing to a pure health technology model, outsourcing non-core production while maintaining proprietary manufacturing for critical medical devices.

Core Business Areas

Personal Health and Connected Care – Core Business
• Sonicare power toothbrushes for intelligent oral healthcare
• Avent maternal, breastfeeding, and baby monitoring product lines
• Sleep and respiratory care devices CPAP, BiPAP, ventilators
• Home-use defibrillators and emergency medical devices
• Patient monitoring systems for hospital-to-home transition
• Hospital respiratory care and sleep diagnostics equipment

Industry Rankings

Corporate Report

Philips is a Netherlands-based health technology company headquartered in Amsterdam. Founded in 1891. Personal Health revenue €3.7B, Connected Care €5.1B. 77,000+ employees across 30+ facilities worldwide.

Business Overview

Philips has completed a decade-long transformation from a consumer electronics conglomerate into a focused health technology company. Its Personal Health division includes market-leading Sonicare and Avent franchises, while Connected Care covers sleep, respiratory, and monitoring solutions.

Key Strengths

Enormous global brand equity built over 130+ years; market-leading positions in Sonicare (oral care) and Avent (maternal care); Connected Care generates €5.1B in sleep and respiratory revenue; strong distribution in non-US markets for sleep devices.

Challenges & Outlook

DOJ/FDA Consent Decree severely restricts US sleep device sales; Respironics recall damaged brand and market share; sleep business lost significant ground to ResMed in the US; ongoing restructuring creates organizational uncertainty.

VerityRank Score

90/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Amsterdam, Netherlands

Founded

1891

Employees

77000+

Factories

30+ factories in 15+ countries

Listing

NYSE: PHG

Categories

Home Medical Devices Brands

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website NYSE: PHG